Teufel Crispin 4
4 · Bellerophon Therapeutics, Inc. · Filed Jun 10, 2019
Insider Transaction Report
Form 4
Teufel Crispin
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-06+25,000→ 25,000 totalExercise: $0.59Exp: 2029-06-06→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option vests in three equal annual installments over a three-year period from the date of Mr. Teufel's board appointment on March 18, 2019.